LicianPro

PRTA stock

Prothena Corporation plc (PRTA) stock news · rev $9.7M

Prothena Corporation plc (PRTA) is a biotechnology company listed on US.

This PRTA news page leads with what Prothena Corporation plc filed — not a scraped headline mill.

No cached 8-K sentence for PRTA yet. We will not pad this page with generic market recap.

Latest reported PRTA revenue for 2025-12-31 was $9.7M. Net income was -$244.1M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. PRTA currently screens at market cap $460.2M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the PRTA stock page; for the tape open the quote page.

PRTA stock news FAQ

What are PRTA's latest revenue and net income?

Latest cached Prothena Corporation plc (PRTA) revenue for Dec 31, 2025 was $9.7M. Net income was -$244.1M. Statements: https://lician.com/financials/prta

How did PRTA revenue change from the prior cached period?

Cached Prothena Corporation plc (PRTA) revenue was down 92.8% from $135.2M (Dec 31, 2024) to $9.7M (Dec 31, 2025). Statements: https://lician.com/financials/prta

What is PRTA's market cap?

Prothena Corporation plc (PRTA) market cap is $460.2M on the latest cached fundamentals snapshot.

What kind of company is PRTA?

Prothena Corporation plc (PRTA) is a biotechnology company listed on US.

Where is PRTA stock news listed?

Cached stock news for Prothena Corporation plc (PRTA) is listed at https://lician.com/news/prta. Filings: https://lician.com/sec/prta

Not investment advice.

Full PRTA analysis